MGC57346 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.374200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.697800E-01
Normal-vs-Stage2
6.341000E-01
Normal-vs-Stage3
5.056000E-01
Normal-vs-Stage4
9.671400E-01
Stage1-vs-Stage2
9.700600E-03
Stage1-vs-Stage3
6.774000E-02
Stage1-vs-Stage4
2.187400E-01
Stage2-vs-Stage3
4.638400E-01
Stage2-vs-Stage4
5.414000E-01
Stage3-vs-Stage4
4.128600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.294000E-01
Normal-vs-AfricanAmerican
3.111200E-01
Normal-vs-Asian
1.102180E-01
Caucasian-vs-AfricanAmerican
5.372500E-04
Caucasian-vs-Asian
4.441500E-03
AfricanAmerican-vs-Asian
5.018800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.612400E-01
Normal-vs-Female
6.084800E-01
Male-vs-Female
1.573020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.234600E-01
Normal-vs-Age(41-60Yrs)
8.429600E-01
Normal-vs-Age(61-80Yrs)
4.327400E-01
Normal-vs-Age(81-100Yrs)
3.886800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.477980E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.564100E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.535000E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.704900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.049430E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.640800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.487200E-01
Normal-vs-Daily Drinker
7.451400E-01
Normal-vs-Weekly Drinker
1.330820E-01
Normal-vs-Occasional Drinker
6.577200E-01
Normal-vs-Social Drinker
8.060800E-01
Non Drinker-vs-Daily Drinker
4.536200E-01
Non Drinker-vs-Weekly Drinker
2.392200E-01
Non Drinker-vs-Occasional Drinker
4.190300E-02
Non Drinker-vs-Social Drinker
4.401400E-01
Daily Drinker-vs-Weekly Drinker
1.052390E-01
Daily Drinker-vs-Occasional Drinker
1.339790E-01
Daily Drinker-vs-Social Drinker
9.207200E-01
Weekly Drinker-vs-Occasional Drinker
7.076400E-03
Weekly Drinker-vs-Social Drinker
1.182240E-01
Occasional Drinker-vs-Social Drinker
2.241600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.956300E-02
Normal-vs-Grade 2
1.547800E-02
Normal-vs-Grade 3
3.185800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.085600E-01
Grade 1-vs-Grade 3
8.400200E-01
Grade 1-vs-Grade 4
9.956300E-02
Grade 2-vs-Grade 3
2.105200E-01
Grade 2-vs-Grade 4
1.547800E-02
Grade 3-vs-Grade 4
3.185800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.634600E-01
Normal-vs-NonDiabetic
8.525600E-01
Diabetic-vs-NonDiabetic
7.007600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.562800E-01
Normal-vs-NoPancreatitis
7.098400E-01
Pancreatitis-vs-NoPancreatitis
6.563800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.944000E-01
Normal-vs-N1
6.731000E-01
N0-vs-N1
5.971600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.251200E-01
Normal-vs-TP53-NonMutant
9.587400E-01
TP53-Mutant-vs-TP53-NonMutant
3.695400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
